Fennec Pharmaceuticals Inc (FENC): Rasio rega marang pendapatan

Tandha merek Fennec (FENC)

The implementation of software robots for processing trial data optimizes Fennec Pharmaceuticals (FENC) processes, which is reflected in the price action. The price-to-sales ratio demonstrates a current trend where 5.80 becomes the new value of the indicator. Pedmark's monopoly guarantees high margins and cash flow, while the focus on protecting children's hearing creates a sustainable market niche for this vital treatment.

FENC Multiplikator P/S Fennec Pharmaceuticals (09.04.2023 - 13.11.2026)

Fennec Pharmaceuticals Inc (FENC) - rincian metrik lan laporan keuangan

- kuotasi saiki lan rata-rata prakiraan nilai:
Rega bursa fennecpharma.com|FENC - Bagan rega target
- data kapitalisasi bursa:
Nilai pasar Fennec Pharmaceuticals Inc|FENC - Nilai Total Perusahaan
- statistik nilai buku emiten:
Nilai Aset Bersih saben Saham Fennec Pharmaceuticals|FENC - Kapitalisasi Buku|Rasio Nilai Pasar marang Ekuitas fennecpharma.com|FENC - Gunggung Aset Perusahaan
- indikator beban kredit lan likuiditas emiten:
Utang marang Modal Fennec Pharmaceuticals|FENC - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal Fennec|FENC - Gunggung utang perusahaan|Utang marang modal buku Fennec Pharmaceuticals Inc|FENC - Utang jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Fennec Pharmaceuticals|Likuiditas darurat fennecpharma.com
- data bathi lan kelipatan valuasi:
FENC - Bathi resik perusahaan|Penghasilan resik sing dikarepake Fennec Pharmaceuticals|FENC - Pangali P/E|Pangali Forward P/E Fennec Pharma|FENC - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Fennec Pharmaceuticals Inc|FENC - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Fennec Pharmaceuticals|FENC - Bathi resik saben saham (EPS TTM)|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan fennecpharma.com|FENC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
FENC - Pendapatan perusahaan|Prakiraan pendapatan perusahaan fennecpharma.com|FENC - Rasio rega marang pendapatan|Kapitalisasi marang prakiraan pendapatan Fennec Pharmaceuticals Inc
Ringkesan analitik perusahaan:fennecpharma.com
Produk seri Fennec

The multiple correlates market capitalization with annual revenue, reflecting investors' willingness to pay a premium per unit of sales as operating metrics shift. In the case of Fennec Pharmaceuticals (FENC), the high valuation is justified by its monopoly position and the patent protection of a unique drug, rendering the P/S ratio a tool for analyzing the premium attributed to a lack of treatment alternatives and visualizing the balance of risks on the chart.

Perusahaan pesaing

INCY - Rega marang dodolan|Rasio rega marang pendapatan HUTCHMED HCM|Nuvation Bio Inc - Rasio rega marang pendapatan|DAWN - Rasio rega marang pendapatan|Rega marang dodolan Monopar Corp|INBX: Multiplikator P/S|Multiplikator rega marang pendapatan I-Mab Biopharma IMAB|Kapitalisasi marang pendapatan HRTX|Rega marang dodolan Nuvectis Pharma Inc. NVCT|Kapitalisasi marang pendapatan CHRS (Coherus)|CRBP (Corbus Pharmaceuticals, Inc.) - Rasio kapitalisasi pasar marang pendapatan|Cardiff Oncology - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan BYSI (beyondspringpharma.com)|BioAtla Corp - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan LIXT (Lixte Biotechnology Holdings Inc.)|CTXR: Multiplikator P/S|Rega marang dodolan Cellectar Corp (CLRB)|Rasio rega marang pendapatan BioLineRx Ltd.|CANF: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S APRE|Multiplikator P/S kaziatherapeutics.com (KZIA)|Rasio rega marang pendapatan Silexion Therapeutics SLXN|NCNA (NuCana PLC) - Rasio rega marang dodolan|CMRX: Kapitalisasi marang pendapatan|Rega marang dodolan cyclacel.com|GTHX: Multiplikator P/S|Rasio rega marang dodolan KRON (Kronos Bio Inc)|KTRA (Kintara) - Multiplikator P/S|Rega marang dodolan Oncternal Corp ONCT|Rasio rega marang pendapatan Portage Biotech Inc. (PRTG)